David Westenberg
Stock Analyst at Piper Sandler
(1.64)
# 1449
Out of 5,240 analysts
160
Total ratings
55.42%
Success rate
11.77%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Akoya Biosciences | Reiterates: Overweight | 4 3 | 2.66 | 12.78% | 7 | Nov 19, 2024 | |
Natera | Maintains: Overweight | 150 200 | 165.72 | 20.69% | 13 | Nov 18, 2024 | |
Tempus AI | Reiterates: Neutral | 40 70 | 31.84 | 119.85% | 2 | Nov 12, 2024 | |
Pacific Biosciences | Maintains: Neutral | 2 3 | 1.84 | 35.87% | 6 | Nov 11, 2024 | |
Illumina | Maintains: Overweight | 195 185 | 136.28 | 35.75% | 14 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 26 22 | 17.17 | 28.13% | 6 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 85 75 | 54.26 | 38.22% | 9 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 8 9 | 7.25 | 17.24% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 6 7 | 6.04 | 15.89% | 10 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 520 435 | 418.22 | 4.01% | 9 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 150 165 | 152.81 | 7.98% | 5 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 235 240 | 234.56 | 2.32% | 2 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 195 210 | 164.36 | 27.77% | 9 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 34 | 37.25 | -8.72% | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 18 | 12 | 45.83% | 9 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 19 16 | 11.69 | 36.87% | 8 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 20 | 13.87 | 44.2% | 7 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 3 | 2.17 | 38.25% | 7 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 1 1 | n/a | n/a | 5 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 170 165 | n/a | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 30 | n/a | n/a | 2 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 44 | n/a | n/a | 2 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | n/a | n/a | n/a | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Nov 21, 2017 |